Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
| Actual shortage: | 246 (8%) | |
| Anticipated shortage: | 15 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PREGABALIN | 225MG | CAPSULE | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216729 |
| APO-PREGABALIN | 25MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-05-08 | 216732 |
| APO-PREGABALIN | 300MG | CAPSULE | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216735 |
| APO-PREGABALIN | 50MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-06-02 | 216738 |
| APO-PREGABALIN | 75MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-05-08 | 216741 |
| APO-FINGOLIMOD | 0.5MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-05-10 | 216744 |
| APO-METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-02-23 | 217300 |
| APO-TRYPTOPHAN | 500MG | TABLET | Resolved | 2024-01-26 | 2024-04-05 | 217469 |
| APO-MIDODRINE | 5MG | TABLET | Resolved | 2024-01-26 | 2024-05-24 | 217472 |
| ZAMINE 28 | 0.03MG 3MG | TABLET | Resolved | 2024-01-26 | 2024-03-08 | 217475 |
| APO-ATORVASTATIN | 80MG | TABLET | Resolved | 2024-01-26 | 2024-02-16 | 217478 |
| APO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-05-31 | 217481 |
| APO-BUSPIRONE | 10MG | TABLET | Actual shortage | 2024-01-26 | 2024-02-02 | 217484 |
| APO-GLICLAZIDE | 80MG | TABLET | Resolved | 2024-01-26 | 2024-03-15 | 217487 |
| APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2024-01-26 | 2024-03-01 | 217490 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2024-02-02 | 2024-03-15 | 218370 |
| APO-ATORVASTATIN | 40MG | TABLET | Resolved | 2024-02-02 | 2024-03-22 | 218373 |
| APO-METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-02-02 | 2024-02-23 | 218376 |
| APO-MELOXICAM | 1.5G | SUSPENSION | Actual shortage | 2024-02-02 | 2024-05-17 | 218379 |
| APO-CINACALCET | 60MG | TABLET | Resolved | 2024-02-02 | 2024-03-22 | 218382 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CEFPROZIL | 500MG | TABLET | Discontinued | 2018-04-04 | 2018-10-05 | 44945 |
| APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
| APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-08 | 60157 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2018-09-07 | 2019-12-20 | 60163 |
| APO-AMOXI | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60171 |
| APO-AMOXI | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60246 |
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60249 |
| APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
| APO-ATENOL TAB 100MG | 100MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60261 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60267 |
| APO-ATOMOXETINE | 60MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60273 |
| APO-ATORVASTATIN | 10MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60276 |
| APO-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60279 |
| APO-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-11-09 | 60282 |
| APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |